Primary liver cancer arises either from hepatocytic or biliary lineage cells, giving rise to
hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICCA). Combined …

The low incidence of combined hepatocellular cholangiocarcinoma (cHCC-CCA) is an
important factor limiting research progression. Our study extensively included nearly three …

Background: Combined hepatocellular-cholangiocarcinoma (cHCC-iCCA) is a rare type of
primary liver cancer displaying characteristics of both hepatocytic and cholangiocytic …

Background & Aims Management of combined hepatocellular-cholangiocarcinoma (cHCC-
CCA) is not well-defined. Therefore, we evaluated the management of cHCC-CCA using an …

Bone regeneration heavily relies on bone marrow mesenchymal stem cells (BMSCs).
However, recruiting endogenous BMSCs for in situ bone regeneration remains challenging …

Hepatocellular carcinoma (HCC) is the fourth leading cause of malignancy worldwide, and
its progression is influenced by the immune microenvironment. Natural killer (NK) cells are …

Simple Summary To provide a comprehensive molecular characterization of combined
hepatocholangiocarcinomas (cHCC-CCA), the MALDI (Matrix Assisted Laser Desorption …

Primary liver cancer (PLC) is the fourth leading cause of cancerrelated deaths and is having
an increasing impact on society (https://gco. iarc. fr/). When thinking of liver malignancies …

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer
associated with an appalling prognosis. The diagnosis and management of this entity have …

Genetic alterations including fusions in fibroblast growth factor receptor 2 (FGFR2) are
detected in 10–20% of intrahepatic cholangiocarcinoma (iCCA), and FGFR2 inhibitors are …